Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences

2018-04-23T15:15:11-04:00October 7th, 2013|News|

NEUTROPENIC MOUSE THIGH MODEL NOW OFFERED BY NOBLE LIFE SCIENCES Neutropenic Mouse Thigh Model Now Offered by Noble Life SciencesGaithersburg, MD; October 7, 2013 – Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD), has successfully developed a neutropenic mouse thigh model of infection and demonstrated its use in a study evaluating vancomycin for the treatment of Staphylococcus aureus infection. The model will serve as a new Noble service for the evaluation of the efficacy of novel anti-microbial compounds in the treatment of microbial infections.Complicated skin and soft tissue infections are frequently encountered in clinical practice and [...]

Noble Awards $25,000 In Research Services to Synam Vaccine

2018-04-23T15:11:56-04:00April 16th, 2013|News|

NOBLE AWARDS $25,000 IN RESEARCH SERVICES TO SYNAM VACCINE Noble Awards $25,000 in Research Services to SynAm VaccineContributes Drug Development Services through InvestMaryland Business CompetitionNoble Life Sciences, Inc. (Gaithersburg, MD) awarded $25,000 of its drug development contract research services to SynAm Vaccine (Rockville, MD) as part of the InvestMaryland Challenge business competition.  Organized by the state of Maryland, the business plan competition awards $300,000 in grants and $125,000 in business services to early-stage companies in life science and high tech.  The goal of the program is to build a pipeline of companies for growth in Maryland. Noble will provide [...]